Sarcopenia augments the risk of excess weight on COVID-19 hospitalization: A prospective study using the Lifelines COVID-19 cohort

•The presence of sarcopenic overweight or obesity had a greater risk of COVID-19 hospitalization, compared with overweight or obesity alone.•Sarcopenia augments the risk of worse COVID-19 outcomes, after adjusting for lifestyle factors.•More research on sarcopenic overweight or obesity and its relat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nutrition (Burbank, Los Angeles County, Calif.) Los Angeles County, Calif.), 2024-05, Vol.121, p.112361-112361, Article 112361
Hauptverfasser: Zhu, Yinjie, Mierau, Jochen O., Bakker, Stephan J.L., Dekker, Louise H., Navis, Gerjan J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•The presence of sarcopenic overweight or obesity had a greater risk of COVID-19 hospitalization, compared with overweight or obesity alone.•Sarcopenia augments the risk of worse COVID-19 outcomes, after adjusting for lifestyle factors.•More research on sarcopenic overweight or obesity and its related health outcomes outside geriatric settings is warranted. We investigated the associations of sarcopenia alone, overweight or obesity, and sarcopenic overweight or obesity with COVID-19 hospitalization. Participants from the Lifelines COVID-19 cohort who were infected with COVID-19 were included in this study. Sarcopenia was defined as a relative deviation of muscle mass of ≤ –1.0 SD from the sex-specific mean 24-h urinary creatinine excretion. Overweight or obesity was defined as a body mass index ≥ 25 kg/m2. Sarcopenic overweight or obesity was defined as the presence of overweight or obesity and low muscle mass. COVID-19 hospitalization was self-reported. Logistic regression models were used to analyze the associations of sarcopenia alone, overweight or obesity, and sarcopenic overweight or obesity with COVID-19 hospitalization. Of the 3594 participants infected with COVID-19 and recruited in this study, 173 had been admitted to the hospital. Compared with the reference group, individuals with overweight or obesity and sarcopenic overweight or obesity were 1.78-times and 2.09-times more likely to have been hospitalized for COVID-19, respectively, whereas sarcopenia alone did not increase the risk of COVID-19 hospitalization. In this middle-aged population, sarcopenic overweight or obesity elevated the risk of hospitalization for COVID-19 in those infected with COVID-19 more than overweight or obesity alone. These data support the relevance of sarcopenic overweight or obesity as a risk factor beyond the geriatric setting and should be considered in risk stratification in future public health and vaccination campaigns.
ISSN:0899-9007
1873-1244
DOI:10.1016/j.nut.2024.112361